| ［1］ Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide［J］. J Pathol, 1999,189(1):12-19. ［2］ TunstallPedoe H. Preventing chronic diseases. A vital investment: WHO global report. geneva: world health organization［J］. Int J Epidemiol, 2006, 19 (1):200-218. ［3］ Ansink AC. Cervical cancer in developing countries: how can we reduce the burden? Awareness raising, screening, treatment and palliation［J］. Trop Doct, 2007,37(2):67-70. ［4］ Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer ( IBSCC) study group［J］. J Natl Cancer Inst, 1995, 87 (11): 796-802. ［5］ Jung WW, Chun T, Sul D, et al. Strategies against human papillomavirus infection and cervical cancer［J］. J Microbiol, 2004, 42(4):255-266. ［6］ Knoepp SM, Kuebler DL, Wilbur DC. Correlation between hybrid capture Ⅱ highrisk human papillomavirus DNA test chemiluminescence intensity from cervical samples with followup histologic results: a cytologic/histologic review of 367 cases［J］. Cancer Cytopathol, 2010, 118(4):209-217. ［7］ Wu RF, Liu ZH, Zhou QZ, et al. Prevalence of highrisk human papillomavirus and incidence of cervical intraepithelial neoplasia in female populations in Shenzhen, Guangdong Province［J］. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2010, 32(1):90-95. ［8］ Lurchachaiwong W, Junyangdikul P, Payungporn S, et al. Relationship between hybrid capture Ⅱ ratios and DNA amplification of E1, E6 and L1 genes used for the detection of human papillomavirus in samples with different cytological findings［J］. Asian Pac J Allergy Immunol, 2009, 27(4):217-224. ［9］ 肖克林, 吴丽娟, 王 敏, 等. 杂交捕获法和PCRRDB法检测妇女HPV感染的比较［J］.国际检验医学杂志, 2009,30(6):545-547. ［10］ 乌兰娜，吴瑞芳，周艳秋，等. 人乳头瘤病毒基因亚型与宫颈病变的关系［J］. 中国妇产科临床杂志，2005，6(5):346-350. ［11］ 高 琼, 吴 意, 韦创建, 等. HPV基因分型诊断在宫颈癌筛查中的应用［J］.中国热带医学, 2008, 8(7):1086-1087. ［12］ 林广玲, 翁建盛, 林小荣, 等. 基因芯片人乳头瘤病毒分型在妇女生殖道病变中的应用［J］.国际检验医学杂志, 2007, 28(4):292-294. ［13］ Else EA, Swoyer R, Zhang Y, Comparison of realtime multiplex human papillomavirus (HPV) PCR assays with INNOLiPA HPV genotyping extra assay［J］. J Clin Microbiol, 2011, 49（5）:1907-1912. ［14］ Lee JH, Lee NW, Hong SW, et al. Establishment of an efficient multiplex realtime PCR assay for human papillomavirus genotyping in cervical cytology specimens: comparison with hybrid capture Ⅱ［J］. Cytopathology, 2010, 22(4):261-268. ［15］ 汤惠茄, 吴瑞芳, 周艳秋, 等. 不同程度宫颈病变感染人乳头瘤病毒的亚型种类［J］.实用医学杂志, 2007, 23(9):1334-1336. ［16］ Lepique AP, Rabachini T, Villa LL. HPV vaccination: the beginning of the end of cervical cancer? A review［J］. Mem Inst Oswaldo Cruz, 2009,104(1):1-10. ［17］ 朱一剑, 丁显平, 周仲春, 等. 妇科疾病中人乳头瘤病毒感染的分子流行病学调查［J］.中国妇幼保健, 2007, 23(19):2691-2694. ［18］ 吴晓静, 任建功, 刘永江, 等. 尖锐湿疣样本中HPV病毒的分子检测［J］.遗传, 2005, 27(5):699-704. ［19］ Wright JD, Herzog TJ. Human papillomavirus: emerging trends in detection and management［J］. Curr Womens Health Rep, 2002, 2(4): 259-265. |
